These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34596577)

  • 1. Trends in regional morphological changes in the brain after the resolution of hypercortisolism in Cushing's disease: a complex phenomenon, not mere partial reversibility.
    Jiang H; Yang W; Sun Q; Liu C; Bian L
    Endocr Connect; 2021 Oct; 10(11):1377-1386. PubMed ID: 34596577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible and the irreversible structural alterations on brain after resolution of hypercortisolism in Cushing's disease.
    Jiang H; Liu C; Pan SJ; Ren J; He NY; Sun YH; Bian LG; Yan FH; Yang WJ; Sun QF
    Steroids; 2019 Nov; 151():108457. PubMed ID: 31326450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric magnetic resonance imaging analysis in patients with short-term remission of Cushing's disease.
    Jiang H; Ren J; He NY; Liu C; Sun YH; Jian FF; Bian LG; Shen JK; Yan FH; Pan SJ; Sun QF
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):367-374. PubMed ID: 28543178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible Alterations of Susceptibility in Cushing's Disease: A Longitudinal QSM Study.
    Jiang H; Li Z; Sun Y; Ren J; Yan F; Sun Q; Wei H; Bian L
    J Clin Endocrinol Metab; 2023 Jul; 108(8):2007-2015. PubMed ID: 36722202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered spontaneous brain activity in Cushing's disease: a resting-state functional MRI study.
    Jiang H; He NY; Sun YH; Jian FF; Bian LG; Shen JK; Yan FH; Pan SJ; Sun QF
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):367-376. PubMed ID: 27859451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region-specific disturbed iron redistribution in Cushing's disease measured by magnetic resonance imaging-based quantitative susceptibility mapping.
    Jiang H; Li Z; Yang W; Sun Y; Yan F; Sun Q; Wei H; Bian L
    Clin Endocrinol (Oxf); 2022 Jul; 97(1):81-90. PubMed ID: 35170794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered gray and white matter microstructure in Cushing's disease: A diffusional kurtosis imaging study.
    Jiang H; He NY; Sun YH; Jian FF; Bian LG; Shen JK; Yan FH; Pan SJ; Sun QF
    Brain Res; 2017 Jun; 1665():80-87. PubMed ID: 28438531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal and cerebellar atrophy in patients with Cushing's disease.
    Burkhardt T; Lüdecke D; Spies L; Wittmann L; Westphal M; Flitsch J
    Neurosurg Focus; 2015 Nov; 39(5):E5. PubMed ID: 26646929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological changes of cerebellar substructures in temporal lobe epilepsy: A complex phenomenon, not mere atrophy.
    Marcián V; Mareček R; Koriťáková E; Pail M; Bareš M; Brázdil M
    Seizure; 2018 Jan; 54():51-57. PubMed ID: 29268230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered neural processing of emotional faces in remitted Cushing's disease.
    Bas-Hoogendam JM; Andela CD; van der Werff SJ; Pannekoek JN; van Steenbergen H; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Biermasz NR; van der Wee NJ; Pereira AM
    Psychoneuroendocrinology; 2015 Sep; 59():134-46. PubMed ID: 26092780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study.
    Andela CD; van der Werff SJ; Pannekoek JN; van den Berg SM; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Romijn JA; Tiemensma J; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2013 Dec; 169(6):811-9. PubMed ID: 24031092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential associations between immune signaling genes, deactivated microglia, and oligodendrocytes and cortical gray matter loss in patients with long-term remitted Cushing's disease.
    Bauduin SEEC; den Rooijen ILB; Meijer M; van der Werff SJA; Keo A; Dzyubachyk O; Pereira AM; Giltay EJ; van der Wee NJA; Meijer OC; Mahfouz A
    Psychoneuroendocrinology; 2021 Oct; 132():105334. PubMed ID: 34225183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease.
    van der Werff SJ; Andela CD; Nienke Pannekoek J; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Biermasz NR; Pereira AM; van der Wee NJ
    Neuroimage Clin; 2014; 4():659-67. PubMed ID: 24936417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aging-liked alterations in Cushing's disease: A neurite orientation dispersion and density imaging (NODDI) study.
    Jiang H; Can-Xin X; Pan SJ; Na-Ying H; Sun YH; Yan FH; Bian LG; Liu C; Sun QF
    J Neurol Sci; 2020 Jun; 413():116769. PubMed ID: 32169741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hypercortisolism on development of atherosclerotic changes in blood vessels].
    Jezková J; Marek J; Prázný M; Krsek M; Malícková K; Rosická M; Jarkovská Z; Pecen L
    Vnitr Lek; 2003 Aug; 49(8):656-67. PubMed ID: 14518092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hypercortisolism disrupts the principal functional gradient in Cushing's disease: A multi-scale connectomics and transcriptomics study.
    Shang G; Zhou T; Yu X; Yan X; He K; Liu B; Feng Z; Xu J; Zhang Y; Yu X
    Neuroimage Clin; 2024; 43():103652. PubMed ID: 39146836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing's Syndrome Effects on the Thyroid.
    Paragliola RM; Corsello A; Papi G; Pontecorvi A; Corsello SM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.
    Friedman TC; Ghods DE; Shahinian HK; Zachery L; Shayesteh N; Seasholtz S; Zuckerbraun E; Lee ML; McCutcheon IE
    Horm Metab Res; 2010 Nov; 42(12):874-81. PubMed ID: 20803415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of De Quervain's Thyroiditis after Resolution of Hypercortisolism following Pasireotide Treatment for Cushing's Disease and Surgery for an Adrenocortical Adenoma: Report of Two Cases.
    Efstathiadou ZA; Sykja A; Anagnostis P; Panagiotou A; Kita M
    Eur Thyroid J; 2014 Mar; 3(1):69-72. PubMed ID: 24847470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).
    Findling JW; Raff H
    Eur J Endocrinol; 2017 May; 176(5):R205-R216. PubMed ID: 28179447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.